|
FGFR3–IGH
(HGNC:3690, HGNC:5477)
|
plasma cell myeloma
(MONDO_0009693)
|
strong |
moderate |
strong |
moderate |
weak |
|
|
FGFR1–FN1
(HGNC:3688, HGNC:3778)
|
MONDO:0018124
(MONDO:0018124)
|
strong |
strong |
moderate |
strong |
weak |
|
|
FN1–FGFR2
(HGNC:3778, HGNC:3689)
|
|
strong |
moderate |
moderate |
strong |
weak |
|
|
FGFR1–RET
(HGNC:3688, HGNC:9967)
|
thyroid gland papillary carcinoma
(MONDO_0005075)
|
weak |
weak |
weak |
weak |
weak |
|
|
FGFR1–PLAG1
(HGNC:3688, HGNC:9045)
|
|
strong |
weak |
weak |
moderate |
weak |
|
|
EWSR1–POU5F1
(HGNC:3508, HGNC:9221)
|
MONDO:0005102
(MONDO:0005102)
|
strong |
moderate |
moderate |
moderate |
weak |
|
|
FGFR1–FGFR3
(HGNC:3688, HGNC:3690)
|
MONDO:0009693
(MONDO:0009693)
|
moderate |
moderate |
moderate |
moderate |
weak |
|
|
FGF13–MCF2
(HGNC:3670, HGNC:6940)
|
|
weak |
weak |
weak |
weak |
weak |
|
|
EWSR1–PLAGL1
(HGNC:3508, HGNC:9046)
|
MONDO:0021193
(MONDO:0021193)
|
weak |
weak |
weak |
weak |
weak |
|
|
EWSR1–NR4A3
(HGNC:3508, HGNC:7982)
|
MONDO:0012825
(MONDO:0012825)
|
strong |
strong |
moderate |
strong |
weak |
|
|
EWSR1–GDNF
(HGNC:3508, HGNC:4232)
|
clear cell sarcoma
(MONDO_0002926)
|
weak |
weak |
weak |
weak |
weak |
|
|
EWSR1–PBX3
(HGNC:3508, HGNC:8634)
|
MONDO:0003158
(MONDO:0003158)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
EWSR1–PBX1
(HGNC:3508, HGNC:8632)
|
myoepithelial tumor
(MONDO_0002380)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
EWSR1–NFATC1
(HGNC:3508, HGNC:7775)
|
MONDO:0006500
(MONDO:0006500)
|
weak |
weak |
weak |
moderate |
weak |
|
|
EWSR1–MYB
(HGNC:3508, HGNC:7545)
|
MONDO:0044903
(MONDO:0044903)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
ETV6–PDGFRA
(HGNC:3495, HGNC:8803)
|
MONDO:0018881
(MONDO:0018881)
|
moderate |
moderate |
moderate |
strong |
weak |
|
|
ETV6–PAX5
(HGNC:3495, HGNC:8619)
|
MONDO:0004967
(MONDO:0004967)
|
strong |
strong |
moderate |
strong |
weak |
|
|
MECOM–PSMD2
(HGNC:3498, HGNC:9559)
|
acute myeloid leukemia
(MONDO_0018874)
|
weak |
weak |
weak |
weak |
weak |
|
|
MECOM–GATA2
(HGNC:3498, HGNC:4171)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
moderate |
strong |
strong |
weak |
|
|
ETV6–ABL2
(HGNC:3495, HGNC:77)
|
acute myeloid leukemia
(MONDO_0018874)
|
strong |
weak |
moderate |
moderate |
weak |
|